These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke. Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558 [TBL] [Abstract][Full Text] [Related]
5. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study. Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252 [TBL] [Abstract][Full Text] [Related]
6. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke. Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533 [TBL] [Abstract][Full Text] [Related]
7. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator. Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999 [TBL] [Abstract][Full Text] [Related]
9. Early Neurological Deterioration after Recanalization Treatment in Patients with Acute Ischemic Stroke: A Retrospective Study. Zhang YB; Su YY; He YB; Liu YF; Liu G; Fan LL Chin Med J (Engl); 2018 Jan; 131(2):137-143. PubMed ID: 29336360 [TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111 [TBL] [Abstract][Full Text] [Related]
14. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877 [TBL] [Abstract][Full Text] [Related]
15. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Al-Khaled M; Matthis C; Eggers J J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915 [TBL] [Abstract][Full Text] [Related]
16. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581 [TBL] [Abstract][Full Text] [Related]
17. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; du Mesnil de Rochemont R; Singer OC; Jahan R; N Engl J Med; 2015 Jun; 372(24):2285-95. PubMed ID: 25882376 [TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
19. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy. Takagi T; Kato T; Sakai H; Nishimura Y J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483 [TBL] [Abstract][Full Text] [Related]
20. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India. Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]